The therapeutic potential of miRNAs in cardiac fibrosis: where do we stand?
about
Advances in induced pluripotent stem cells, genomics, biomarkers, and antiplatelet therapy highlights of the year in JCTR 2013.Sphingosine 1-Phosphate Receptors: Do They Have a Therapeutic Potential in Cardiac Fibrosis?Hydrogen Sulfide Donor GYY4137 Protects against Myocardial Fibrosis.Aging and the cardiac collagen matrix: Novel mediators of fibrotic remodellingMicroRNA-150: A potential regulator in pathogens infection and autoimmune diseases.miR-19b controls cardiac fibroblast proliferation and migration.The Role of c-SKI in Regulation of TGFβ-Induced Human Cardiac Fibroblast Proliferation and ECM Protein Expression.
P2860
Q30359241-38E834CD-D8A1-4F1D-A360-44E507621B5DQ33753317-99CD6E1D-F2F8-4E0F-B6F0-E43CE80CBB53Q35640723-FBFE75F4-467B-47A5-9284-E033F780C7AAQ37096257-5F5BBDE9-66B7-4D90-9A16-1660712A5336Q41044723-500397AC-27D2-46D7-8580-59574D2AFDDBQ41880442-951391BA-88B2-4B7D-9E4F-AF8AD6879AA1Q48220874-30ABEA3C-ECD7-44ED-862F-EEDC7AC05AC3
P2860
The therapeutic potential of miRNAs in cardiac fibrosis: where do we stand?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The therapeutic potential of miRNAs in cardiac fibrosis: where do we stand?
@en
type
label
The therapeutic potential of miRNAs in cardiac fibrosis: where do we stand?
@en
prefLabel
The therapeutic potential of miRNAs in cardiac fibrosis: where do we stand?
@en
P2860
P1476
The therapeutic potential of miRNAs in cardiac fibrosis: where do we stand?
@en
P2093
Esther E Creemers
Yigal M Pinto
P2860
P2888
P304
P356
10.1007/S12265-013-9483-Y
P407
P577
2013-07-03T00:00:00Z
P5875
P6179
1015536017